2023 was a troublesome calendar year with the biopharma industry, with several providers downsizing and restructuring their workforces to remain afloat. You will discover signs of Restoration, as mergers and acquisitions picked up throughout the pharmaceutical and life sciences sector within the latter Element of 2023 and also have ongoing https://sites.google.com/view/bio-sites/blog